Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study.
Saved in:
| Title: | Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study. |
|---|---|
| Authors: | Ross JDC; Department of Sexual Health and HIV, Birmingham University Hospitals NHS Foundation Trust, Birmingham, UK., Wilson J; Department of Genitourinary Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Workowski KA; Department of Medicine, Emory University, Atlanta, GA, USA., Taylor SN; Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA, USA., Lewis DA; Sydney Medical School, Westmead Campus, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia., Gatsi S; GSK, Collegeville, PA, USA., Flight W; GSK, London, UK., Scangarella-Oman NE; GSK, Collegeville, PA, USA., Jakielaszek C; GSK, Collegeville, PA, USA., Lythgoe D; GSK, Stevenage, UK., Powell M; GSK, Durham, NC, USA., Janmohamed S; GSK, London, UK., Absalon J; GSK, Collegeville, PA, USA., Perry C; GSK, Collegeville, PA, USA. Electronic address: caroline.r.perry@gsk.com. |
| Source: | Lancet (London, England) [Lancet] 2025 May 03; Vol. 405 (10489), pp. 1608-1620. Date of Electronic Publication: 2025 Apr 14. |
| Publication Type: | Journal Article; Multicenter Study; Clinical Trial, Phase III; Randomized Controlled Trial; Equivalence Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40245902 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ross+JDC%22">Ross JDC</searchLink>; Department of Sexual Health and HIV, Birmingham University Hospitals NHS Foundation Trust, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Wilson+J%22">Wilson J</searchLink>; Department of Genitourinary Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Workowski+KA%22">Workowski KA</searchLink>; Department of Medicine, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Taylor+SN%22">Taylor SN</searchLink>; Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Lewis+DA%22">Lewis DA</searchLink>; Sydney Medical School, Westmead Campus, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Gatsi+S%22">Gatsi S</searchLink>; GSK, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Flight+W%22">Flight W</searchLink>; GSK, London, UK.<br /><searchLink fieldCode="AU" term="%22Scangarella-Oman+NE%22">Scangarella-Oman NE</searchLink>; GSK, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Jakielaszek+C%22">Jakielaszek C</searchLink>; GSK, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Lythgoe+D%22">Lythgoe D</searchLink>; GSK, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Powell+M%22">Powell M</searchLink>; GSK, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Janmohamed+S%22">Janmohamed S</searchLink>; GSK, London, UK.<br /><searchLink fieldCode="AU" term="%22Absalon+J%22">Absalon J</searchLink>; GSK, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Perry+C%22">Perry C</searchLink>; GSK, Collegeville, PA, USA. Electronic address: caroline.r.perry@gsk.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222985213R%22">Lancet (London, England)</searchLink> [Lancet] 2025 May 03; Vol. 405 (10489), pp. 1608-1620. <i>Date of Electronic Publication: </i>2025 Apr 14. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Clinical Trial, Phase III; Randomized Controlled Trial; Equivalence Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985213R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-547X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201406736%22">01406736 </searchLink><i>NLM ISO Abbreviation: </i>Lancet <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40245902 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S0140-6736(25)00628-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1608 Titles: – TitleFull: Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ross JDC – PersonEntity: Name: NameFull: Wilson J – PersonEntity: Name: NameFull: Workowski KA – PersonEntity: Name: NameFull: Taylor SN – PersonEntity: Name: NameFull: Lewis DA – PersonEntity: Name: NameFull: Gatsi S – PersonEntity: Name: NameFull: Flight W – PersonEntity: Name: NameFull: Scangarella-Oman NE – PersonEntity: Name: NameFull: Jakielaszek C – PersonEntity: Name: NameFull: Lythgoe D – PersonEntity: Name: NameFull: Powell M – PersonEntity: Name: NameFull: Janmohamed S – PersonEntity: Name: NameFull: Absalon J – PersonEntity: Name: NameFull: Perry C IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 05 Text: 2025 May 03 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1474-547X Numbering: – Type: volume Value: 405 – Type: issue Value: 10489 Titles: – TitleFull: Lancet (London, England) Type: main |
| ResultId | 1 |